Bone Biologics Corp Stock Price on September 17, 2024
| BBLG Stock | USD 1.22 0.04 3.17% |
Below is the normalized historical share price chart for Bone Biologics Corp extending back to March 31, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bone Biologics stands at 1.22, as last reported on the 1st of December, with the highest price reaching 1.30 and the lowest price hitting 1.10 during the day.
If you're considering investing in Bone Stock, it is important to understand the factors that can impact its price. Bone Biologics is very risky given 3 months investment horizon. Bone Biologics Corp secures Sharpe Ratio (or Efficiency) of 0.0685, which signifies that the company had a 0.0685% return per unit of risk over the last 3 months. We were able to break down and interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.34% are justified by taking the suggested risk. Use Bone Biologics Downside Deviation of 9.6, risk adjusted performance of 0.0489, and Mean Deviation of 9.09 to evaluate company specific risk that cannot be diversified away.
The Bone Biologics' current Total Stockholder Equity is estimated to increase to about 3.1 M, while Common Stock Shares Outstanding is projected to decrease to roughly 250 K. . At this time, Bone Biologics' Price Fair Value is most likely to increase significantly in the upcoming years. Bone Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of March 2016 | 200 Day MA 1.7514 | 50 Day MA 1.6202 | Beta 0.736 |
Bone |
Sharpe Ratio = 0.0685
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | BBLG | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 19.62 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.34 actual daily | 26 74% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Bone Biologics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bone Biologics by adding it to a well-diversified portfolio.
Price Book 0.7925 | Book Value 5.44 | Enterprise Value -560.9 K | Enterprise Value Ebitda 0.1345 | Shares Float 1.7 M |
Bone Biologics Main Headline on 17th of September 2024
Acquisition by Angle Siddhesh Rajendra of 30713 shares of Bo... by Angle Siddhesh Rajendra
Filed transaction by Bone Biologics Corp Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Bone Biologics Valuation on September 17, 2024
It is possible to determine the worth of Bone Biologics on a given historical date. On September 17, 2024 Bone was worth 1.68 at the beginning of the trading date compared to the closed value of 1.73. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bone Biologics stock. Still, in general, we apply an absolute valuation method to find Bone Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bone Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bone Biologics' related companies.
| Open | High | Low | Close | Volume | |
| 1.26 | 1.98 | 1.13 | 1.89 | 161,034,872 | |
09/17/2024 | 1.68 | 1.79 | 1.51 | 1.73 | 4,092,279 |
| 1.75 | 2.34 | 1.73 | 2.08 | 9,390,275 |
| Backtest Bone Biologics | | | Bone Biologics History | | | Bone Biologics Valuation | Previous | Next |
Bone Biologics Trading Date Momentum on September 17, 2024
| On September 18 2024 Bone Biologics Corp was traded for 2.08 at the closing time. The top price for the day was 2.34 and the lowest listed price was 1.73 . The trading volume for the day was 9.4 M. The trading history from September 18, 2024 was a factor to the next trading day price rise. The overall trading delta against the next closing price was 20.23% . The overall trading delta against the current closing price is 54.91% . |
Bone Biologics Corp Fundamentals Correlations and Trends
By evaluating Bone Biologics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bone Biologics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bone financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bone Biologics Stock history
Bone Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bone is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bone Biologics Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bone Biologics stock prices may prove useful in developing a viable investing in Bone Biologics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 263.1 K | 250 K | |
| Net Loss | -1.9 M | -1.9 M |
Bone Biologics Stock Technical Analysis
Bone Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bone Biologics Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Bone Biologics Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bone Biologics December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Bone Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bone Biologics shares will generate the highest return on investment. By undertsting and applying Bone Biologics stock market strength indicators, traders can identify Bone Biologics Corp entry and exit signals to maximize returns
Bone Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bone Biologics' price direction in advance. Along with the technical and fundamental analysis of Bone Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bone to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0489 | |||
| Jensen Alpha | 0.8074 | |||
| Total Risk Alpha | (2.26) | |||
| Sortino Ratio | 0.0898 | |||
| Treynor Ratio | 0.6911 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Bone Stock analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |